BioRN: Maastricht joins the Health Axis Europe
The health research region Maastricht joins the Health Axis Europe. The four leading locations Cambridge (UK), Leuven (Belgium), Maastricht (Netherlands), and Heidelberg (Germany) form an alliance to foster innovation in health across Europe.
Heidelberg (Germany) | During a visit by a delegation of the Employers’ Association of the Province of Limburg (LWV), representatives of the biomedical clusters in Leuven (Belgium), Maastricht (Netherlands), and Heidelberg met at Heidelberg Castle on June 10 to seal the accession of Maastricht to their strategic alliance “Health Axis Europe“. The goal of the alliance is to cross-leverage their innovation resources and thus jointly increase their international competitiveness. The Health Axis Europe was founded on June 8, 2011 by the clusters in Cambridge and Leuven and the BioRN Leading-Edge Cluster in Heidelberg.
The alliance is managed and coordinated by the Health Axis Europe Committee, comprised of key individuals from each cluster representing local industry, science, politics, and venture capital. The parties in the alliance are the University of Leuven, the BioRN Network in Heidelberg, and the Brightlands Consortium in Maastricht, consisting of the Maastricht University, the Maastricht Health Campus and the Chemelot Campus. The partners agreed on the initiation and coordination of cross-border cooperation in research and development and on the support of start-ups.
On June 9, the Biotech Cluster Rhine-Neckar (BioRN) won the tender of the Federal Ministry for Education and Research (BMBF) for the internationalization of leading-edge clusters with its project proposal for the expansion of the Health Axis Europe. In the next four years a portion of the development funds of up to 4 million euros will go to projects of the expanded Health Axis Europe.
The Managing Director of the BioRN Network in Heidelberg, Christian Tidona, said: “The accession of Maastricht to the Health Axis Europe is an important step towards the creation of critical mass in Europe. The fact that the BMBF has again selected Heidelberg for funding is encouraging us to move ahead with the internationalization of our leading-edge cluster.”
The Health Axis Europe Committee will meet in Maastricht in the coming months and will initiate the first joint projects.
BioRN Network, 11 June 2015